comparemela.com

Latest Breaking News On - Maheshj patel - Page 1 : comparemela.com

Merck Presents New Analyses Supporting the Promising Potential of Sotatercept, its Investigational Medicine for Adults with Pulmonary Arterial Hypertension (PAH)

Interim results from SOTERIA open-label extension study represent longest safety and efficacy analysis of sotatercept to date; safety profile of sotatercept consistent with previous studies and efficacy improvements maintained after one year of therapy

United statesAnn arborMariusm hoeperEliav barrMaheshj patelRogier klokVallerie mclaughlinIoanar prestonIoana prestonDominik lautschPopulation health model predicting the longPulmonary hypertension programEuropean respiratory societyMerck research laboratoriesDrug administrationDivision of cardiovascular medicine

Merck Presents New Analyses Supporting the Promising Potential of Sotatercept, its Investigational Medicine for Adults with Pulmonary Arterial Hypertension (PAH)

Exploratory post-hoc analysis of STELLAR shows potential of sotatercept to improve cardiovascular function Interim results from SOTERIA open-label extension study represent longest safety and.

United statesMariusm hoeperMaheshj patelIoana prestonIoanar prestonRogier klokVallerie mclaughlinEliav barrDominik lautschPopulation healthEuropean respiratory societyExchange commissionBristol myers squibbMerck co incTufts university school of medicineDrug administration

vimarsana © 2020. All Rights Reserved.